{
    "article_link": "https://doi.org/10.1038/s41467-023-42565-z",
    "data": [
        {
            "id": "data_1",
            "omics": "Epigenomics",
            "link": "https://ngdc.cncb.ac.cn/gsa-human/document/GSA-Human_Request_Guide_for_Users_us.pdf",
            "format": "bam",
            "source": "Genome Sequence Archive for Human (GSA-human)",
            "public_id": "HRA002815"
        },
        {
            "id": "data_2",
            "omics": "Transcriptomics",
            "link": "https://ngdc.cncb.ac.cn/gsa-human/document/GSA-Human_Request_Guide_for_Users_us.pdf",
            "format": "txt",
            "source": "Genome Sequence Archive for Human (GSA-human)",
            "public_id": "HRA002815"
        },
        {
            "id": "data_3",
            "omics": "Genomics",
            "link": "https://ngdc.cncb.ac.cn/gsa-human/document/GSA-Human_Request_Guide_for_Users_us.pdf",
            "format": "bam",
            "source": "Genome Sequence Archive for Human (GSA-human)",
            "public_id": "HRA002815"
        },
        {
            "id": "data_4",
            "omics": "ChIP-seq",
            "link": "https://epigenomesportal.ca/ihec/grid.html?build=2020-10&assembly=4&institutions=3",
            "format": "bam",
            "source": "Blueprint Epigenomic Consortium",
            "public_id": "EGAD00001002421"
        },
        {
            "id": "data_5",
            "omics": "Transcriptomics",
            "link": "https://ngdc.cncb.ac.cn/gsa-human/document/GSA-Human_Request_Guide_for_Users_us.pdf",
            "format": "txt",
            "source": "Genome Sequence Archive for Human (GSA-human)",
            "public_id": "HRA000119"
        },
        {
            "id": "data_6",
            "omics": "Genomics",
            "link": "https://ngdc.cncb.ac.cn/gsa-human/document/GSA-Human_Request_Guide_for_Users_us.pdf",
            "format": "txt",
            "source": "Genome Sequence Archive for Human (GSA-human)",
            "public_id": "HRA005668"
        },
        {
            "id": "data_7",
            "omics": "Epigenomics",
            "link": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE122989",
            "format": "bam",
            "source": "Gene Expression Omnibus (GEO)",
            "public_id": "GSE122989"
        },
        {
            "id": "data_8",
            "omics": "Clinical data",
            "link": "https://gdc.cancer.gov/about-data/publications#/?groups=TARGET-ALL-P2&years=&order=desc",
            "format": "txt",
            "source": "dbGaP",
            "public_id": "phs000464"
        },
        {
            "id": "data_9",
            "omics": "Drug response",
            "link": "https://depmap.org/portal/download",
            "format": "txt",
            "source": "DepMap",
            "public_id": "DepMap_Public_21Q1"
        }
    ],
    "analyses": [
        {
            "id": "analysis_1",
            "analysis_name": "Chromatin accessibility profiling",
            "analysis_data": [
                "data_1"
            ],
            "label": null
        },
        {
            "id": "analysis_2",
            "analysis_name": "Integration of multi-omics data",
            "analysis_data": [
                "data_1",
                "data_3",
                "data_4",
                "data_2"
            ],
            "label": null
        },
        {
            "id": "analysis_3",
            "analysis_name": "Differential analysis of chromatin accessibility between B-ALL and B-cell progenitors",
            "analysis_data": [
                "data_1",
                "data_7"
            ],
            "label": {
                "condition": [
                    "B-ALL",
                    "B-cell progenitors"
                ]
            }
        },
        {
            "id": "analysis_4",
            "analysis_name": "Subtype-specific chromatin accessibility analysis",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "subtypes": [
                    "ETV6::RUNX1",
                    "ZNF384",
                    "Hyperdiploidy",
                    "BCR::ABL1",
                    "BCR::ABL1-like",
                    "TCF3::PBX1",
                    "KMT2A",
                    "PAX5alt",
                    "TCF3::HLF",
                    "Hypodiploidy",
                    "MEF2D",
                    "B-other"
                ]
            }
        },
        {
            "id": "analysis_5",
            "analysis_name": "Allele-specific open chromatin analysis",
            "analysis_data": [
                "data_1",
                "data_3"
            ],
            "label": {
                "status": [
                    "diagnosis",
                    "relapse"
                ]
            }
        },
        {
            "id": "analysis_6",
            "analysis_name": "Treatment-induced chromatin accessibility changes",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "status": [
                    "diagnosis",
                    "relapse"
                ]
            }
        },
        {
            "id": "analysis_7",
            "analysis_name": "ACR-to-gene prediction",
            "analysis_data": [
                "data_1",
                "data_2"
            ],
            "label": null
        },
        {
            "id": "analysis_8",
            "analysis_name": "Survival analysis",
            "analysis_data": [
                "data_1",
                "data_8"
            ],
            "label": {
                "status": [
                    "Group A",
                    "Group B"
                ]
            }
        },
        {
            "id": "analysis_9",
            "analysis_name": "Drug response analysis",
            "analysis_data": [
                "data_2",
                "data_9"
            ],
            "label": {
                "drug_response": [
                    "Cyclophosphamide",
                    "Cytarabine",
                    "Dasatinib",
                    "Dexamethasone",
                    "Doxorubicin",
                    "Etoposide",
                    "Imatinib",
                    "Methotrexate"
                ]
            }
        },
        {
            "id": "analysis_10",
            "analysis_name": "Lineage plasticity gene signature analysis",
            "analysis_data": [
                "data_1",
                "data_2"
            ],
            "label": {
                "lineage_plasticity": [
                    "stem_cell_like",
                    "myeloid_progenitor_like"
                ]
            }
        }
    ],
    "results": [
        {
            "analysis_id": "analysis_1",
            "metrics": "median number of ACRs",
            "value": "138,366",
            "features": []
        },
        {
            "analysis_id": "analysis_3",
            "metrics": "percentage of ACRs in Quies regions",
            "value": "27.95%",
            "features": []
        },
        {
            "analysis_id": "analysis_3",
            "metrics": "overlap with Quies regions",
            "value": "54.94%",
            "features": []
        },
        {
            "analysis_id": "analysis_4",
            "metrics": "number of subtype-specific ACRs",
            "value": "17,981",
            "features": [
                "IL7R",
                "TCL1A",
                "TCF3",
                "RHOA",
                "ELL",
                "MECOM",
                "HOXA9"
            ]
        },
        {
            "analysis_id": "analysis_5",
            "metrics": "percentage of ASOC regions",
            "value": "14.39%",
            "features": [
                "rs7090445",
                "rs13401811"
            ]
        },
        {
            "analysis_id": "analysis_6",
            "metrics": "number of differential ACRs",
            "value": "5911 relapse-high ACRs, 1423 relapse-low ACRs",
            "features": []
        },
        {
            "analysis_id": "analysis_7",
            "metrics": "number of ACR-gene correlations",
            "value": "116,307",
            "features": [
                "1259 genes"
            ]
        },
        {
            "analysis_id": "analysis_7",
            "metrics": "shared genes between subtypes",
            "value": "13.98%",
            "features": [
                "176 genes"
            ]
        },
        {
            "analysis_id": "analysis_8",
            "metrics": "relapse-free survival (RFS)",
            "value": "p = 3.778e−10",
            "features": [
                "Group A",
                "Group B"
            ]
        },
        {
            "analysis_id": "analysis_8",
            "metrics": "overall survival (OS)",
            "value": "p = 5.585e−7",
            "features": [
                "Group A",
                "Group B"
            ]
        },
        {
            "analysis_id": "analysis_9",
            "metrics": "enrichment in drug response genes",
            "value": "p = 0.0029 (Imatinib), p = 0.0184 (Etoposide), p = 0.0167 (Doxorubicin)",
            "features": [
                "Imatinib",
                "Etoposide",
                "Doxorubicin"
            ]
        },
        {
            "analysis_id": "analysis_10",
            "metrics": "enrichment in lineage plasticity-related biological processes",
            "value": "p < 0.05",
            "features": [
                "cell adhesion",
                "migration",
                "locomotion"
            ]
        }
    ]
}